Provided by Tiger Trade Technology Pte. Ltd.

ReShape Lifesciences, Inc.

15.68
0.0000
Volume:- -
Turnover:53.80M
Market Cap:37.41M
PE:-0.16
High:15.68
Open:15.68
Low:15.68
Close:15.68
52wk High:15.68
52wk Low:15.68
Shares:2.39M
Float Shares:2.38M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-96.2212
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Aug 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2025

Major Issues Report

Form 8-K - Current report
Jul 30, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 25, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 25, 2025

Major Issues Report

Form 8-K - Current report
Jul 24, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 24, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 21, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 18, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 15, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 03, 2025

Major Issues Report

Form 8-K - Current report
Jun 26, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
Jun 09, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 28, 2025

Major Issues Report

Form 8-K - Current report
May 20, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]